Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Pediatr Hematol Oncol. 2022 Mar 9;39(7):650–657. doi: 10.1080/08880018.2022.2047850

TABLE 1.

Patient demographics by MRD status.

MRD negative MRD positive p-value
Sex 0.16
 Female 41 (46.1%) 18 (34.0%)
 Male 48 (53.9%) 35 (66.0%)
Race/ethnicity 0.16
 Latinx 51 (57.3%) 37 (69.8%)
 Non-Latinx White 30 (33.7%) 10 (18.9%)
 Non-Latinx Black or Other 8 (9.0%) 6 (11.3%)
Overweight status 0.26
 Not Overweight/Obese 65 (73.6%) 34 (64.2%)
 Overweight/Obese 21 (23.6%) 17 (32.1%)
 Unknown or NA 3 (3.4%) 2 (3.8%)
NCI risk group 0.01
 Standard 57 (64.0%) 22 (41.5%)
 High 32 (36.0%) 31 (58.5%)
Primary Language 0.31
 English 69 (77.5%) 37 (69.8%)
 Spanish 20 (22.5%) 16 (30.2%)
Cytogenetic category 0.44
 Favorable or neutral 78 (87.6%) 44 (83.0%)
 Unfavorable 11 (12.4%) 9 (17.0%)
Latinx Enclave Index Quartiles 0.18
 LEI-1 (Lowest LEI Scores) 12 (13.5%) 4 (7.5%)
 LEI-2 18 (20.2%) 6 (11.3%)
 LEI-3 27 (30.3%) 15 (28.3%)
 LEI-4 (Highest LEI Scores) 32 (36.0%) 28 (52.8%)
Age at Diagnosis 0.02*
 Infant (<1 year) 0 (0.0%) 1 (1.9%)
 Child (1–9 years) 66 (74.2%) 29 (54.7%)
 Adolescent (≥10 years) 23 (25.8%) 23 (43.4%)

All p-values were obtained with the Chi-Squared test, except for *, which was obtained using the Fisher’s Exact Test.